🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

850 results for “Elan” Clear

  1. EXPAREL

    Pacira Ireland Limited

    Spinal Fusion

    phase 1 small molecule completed

    1 trial

  2. Epidiolex 100 mg/mL Oral Solution

    Jazz Pharmaceuticals Ireland Limited

    Electrical Status Epilepticus of Slow-Wave Sleep

    phase 1 small molecule completed

    1 trial

  3. Erwinase

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia

    phase 1 small molecule completed

    1 trial

  4. Erwinia Chrysanthemi asparaginase

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia (ALL)

    phase 1 small molecule terminated

    1 trial

  5. Evixapodlin

    Gilead Sciences Ireland UC

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  6. Exparel Injectable Product

    Pacira Ireland Limited

    Breast Augmentation

    phase 1 small molecule completed

    1 trial

  7. Exparel Injectable Product

    Pacira Ireland Limited

    Bunion

    phase 1 small molecule completed

    1 trial

  8. Extracellular Vesicles from Mesenchymal Stem Cells

    Regeneron Ireland Designated Activity Company (DAC)

    COVID-19 Pneumonia

    phase 1 mab active

    1 trial

  9. FHD-286

    Foghorn Therapeutics

    Metastatic Uveal Melanoma

    phase 1 small molecule terminated

    1 trial

  10. FX201

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 1 mab active

    1 trial

  11. FX301

    Pacira Ireland Limited

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  12. GLA-AF

    Lxo Ireland Designated Activity Company

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  13. GLA-SE

    Lxo Ireland Designated Activity Company

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

  14. GME751

    Sandoz Pty Ltd

    Melanoma

    phase 1 small molecule active

    1 trial

  15. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Melanoma

    phase 1 small molecule completed

    1 trial

  16. GS-0272

    Gilead Sciences Ireland UC

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial

  17. GS-2829

    Gilead Sciences Ireland UC

    Chronic Hepatitis B

    phase 1 mab completed

    1 trial

  18. GSK961081

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    2 trials

  19. GSK961081 15mcg SD

    Theravance Biopharma Ireland Umited

    Pulmonary Disease, Chronic Obstructive

    phase 1 small molecule completed

    1 trial

  20. GTX-102 medium dose fast Period 1 and Period 2

    Grace Therapeutics

    Ataxia Telangiectasia

    phase 1 small molecule active

    1 trial

  21. Gemtuzumab Ozogamicin

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  22. Gilteritinib

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia With FLT3/ITD Mutation

    phase 1 small molecule active

    1 trial

  23. HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    HIV Infections

    phase 1 mab active

    1 trial

  24. HSV 2 Formulation 1

    Lxo Ireland Designated Activity Company

    Genital Herpes

    phase 1 mab terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources